amphotericin-b has been researched along with Pulmonary-Eosinophilia* in 4 studies
4 other study(ies) available for amphotericin-b and Pulmonary-Eosinophilia
Article | Year |
---|---|
Invasive pulmonary mucormycosis: rare presentation with pulmonary eosinophilia.
Fungi can cause a variety of infectious diseases, including invasive mycosis and non-invasive mycosis, as well as allergic diseases. The different forms of mycosis usually have been described as mutually exclusive, independent entities, with few descriptions of overlapping cases. Here, we describe the first reported case of a patient with the complication of pulmonary eosinophilia in the course of invasive mucormycosis.. A 74-year-old Japanese man with asthma-COPD overlap underwent emergency surgery for a ruptured abdominal aortic aneurysm. The surgery was successful, but fever and worsening dyspnea appeared and continued from postoperative day (POD) 10. A complete blood count showed leukocytosis with neutrophilia and eosinophilia, and the chest X-ray showed consolidation of the left upper lung at POD 15. We suspected nosocomial pneumonia together with an exacerbation of the asthma-COPD overlap, and both antibiotics and bronchodilator therapy were initiated. However, the symptoms, eosinophilia and imaging findings deteriorated. We then performed a bronchoscopy, and bronchoalveolar lavage (BAL) fluid analysis revealed an increased percentage of eosinophils (82% of whole cells) as well as filamentous fungi. We first suspected that this was a case of allergic bronchopulmonary mycosis (ABPM) caused by Aspergillus infection and began corticosteroid therapy with an intravenous administration of voriconazole at POD 27. However, the fungal culture examination of the BAL fluid revealed mucormycetes, which were later identified as Cunninghamella bertholletiae by PCR and DNA sequencing. We then switched the antifungal agent to liposomal amphotericin B for the treatment of the pulmonary mucormycosis at POD 29. Despite replacing voriconazole with liposomal amphotericin B, the patient developed septic shock and died at POD 39. The autopsy revealed that filamentous fungi had invaded the lung, heart, thyroid glands, kidneys, and spleen, suggesting that disseminated mucormycosis had occurred.. We describe the first reported case of pulmonary mucormycosis with pulmonary eosinophilia caused by Cunninghamella bertholletiae, which resulted in disseminated mucormycosis. Although it is a rather rare case, two important conclusions can be drawn: i) mycosis can simultaneously cause both invasive infection and a host allergic reaction, and ii) Cunninghamella bertholletiae rarely infects immunocompetent patients. Topics: Aged; Amphotericin B; Antifungal Agents; Aortic Aneurysm, Abdominal; Asthma; Bronchoalveolar Lavage Fluid; Bronchoscopy; Cross Infection; Cunninghamella; Disease Progression; Fatal Outcome; Humans; Male; Mucormycosis; Postoperative Complications; Pulmonary Disease, Chronic Obstructive; Pulmonary Eosinophilia; Radiography, Thoracic; Tomography, X-Ray Computed | 2017 |
Eosinophilic pneumonia caused by Aspergillus niger: is oral cleansing with amphotericin B efficacious in preventing relapse of allergic pneumonitis?
Eosinophilic pneumonia was confirmed by bronchoalveolar lavage fluid examination and transbronchial lung biopsy. Aspergillus niger was cultured from the patient's pharyngeal swab and bronchoalveolar lavage fluid. Inhalation bronchoprovocation test with A. niger antigen was positive. Although the patient's condition improved promptly with 10 mg/day prednisolone administration, dry cough recurred approximately 2 months after completion of this therapy. Severe coughing disappeared on oral cleansing with 300 mg/day amphotericin B, and he recovered completely on 100 mg/day amphotericin B administration. Oral cleansing with amphotericin B may be efficacious in preventing relapses of eosinophilic pneumonia caused by allergic reaction to fungal antigen. Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus niger; Bronchoalveolar Lavage Fluid; Humans; Lung; Male; Middle Aged; Pulmonary Eosinophilia; Secondary Prevention; Skin Tests | 2009 |
Pulmonary eosinophilia in coccidioidal infections.
Two cases of pulmonary eosinophilia associated with coccidioidal infections are reported. Pulmonary eosinophilia in these cases represents a hypersensitivity reaction to the fungus. Histologically, the pulmonary eosinophilia in these cases closely mimicked or appeared identical to idiopathic chronic eosinophilic pneumonia. Coccidioides immitis organisms were rare or absent in the areas of pulmonary eosinophilia. Recognition of this phenomenon is important for proper care of the patient. Topics: Adolescent; Amphotericin B; Coccidioides; Coccidioidomycosis; Diagnosis, Differential; Female; Humans; Ketoconazole; Lung; Lung Diseases, Fungal; Middle Aged; Pulmonary Eosinophilia | 1987 |
[Bronchopulmonary pathology with hypereosinophilia of fungal origin (excluding allergic bronchopulmonary aspergillosis)].
Five cases of eosinophil lung are reported in which the fungus responsible for the affection was not Aspergillus. Documented data include reports on 19 similar cases with a clinical picture suggestive of allergic bronchopulmonary aspergillosis but with negative tests for Aspergillus. The various fungal species isolated included Candida albicans, Penicillium, Geotrichum candidum, Stemphylium lanuginosum, Culvularia lunata, and Drechsleria hawaïensis. Diagnostic criteria are discussed, with particular emphasis on the importance of the inhalation provocation test, as well as possible efficacy of antifungal treatment. Topics: Adult; Aged; Amphotericin B; Aspergillosis, Allergic Bronchopulmonary; Bronchial Provocation Tests; Candidiasis; Diagnosis, Differential; Female; Flucytosine; Geotrichosis; Helminthosporium; Humans; Lung Diseases, Fungal; Male; Miconazole; Middle Aged; Penicillium; Pulmonary Eosinophilia | 1983 |